Prot# CT-2011-01: Phase II Study to Evaluate the Safety, Tolerability and Efficacy of CT-011 Administered Intravenously to Patients with Metastatic Melanoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/9/117/31/14

Funding

  • CureTech Ltd. (CT-2011-01)